Copyright © 2000 by the European Society of Cardiology.
Clinical Perspective
Cost effectiveness of the implantable cardioverter defibrillator
Wessex Cardiothoracic Centre, Southampton General Hospital, Southampton, U.K.
revised June 29, 1999; accepted July 7, 1999
f1 Correspondence: Dr J. M. Morgan, Department of Electrophysiology, Wessex Cardiothoracic Centre, Southampton University Hospitals, Tremona Road, Southampton, U.K.
References
- Hallstrom A, Greene H, Wyse G. Antiarrhythmic versus implantable defibrillators (AVID)rationale, design, and methods. Am J Cardiol. 1995;75:470475[CrossRef][Web of Science][Medline]
- Moss A, Akiyama T, Cannom D. Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. PACE. 1991;14:920927
- Goldman L, Gordon DJ, Rifkind BM. Cost and health implications of cholesterol lowering. Circulation. 1992;85:19601968[Abstract]
- Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JTJ, Ruskin JN. An analysis of the cost effectiveness of the implantable defibrillator. Circulation. 1990;81:91100
[Abstract/Free Full Text] - Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NA, Pauker SG. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol. 1992;19:13231334[Abstract]
- Anderson MH, Camm AJ. Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy. Br Heart J. 1993;69:8392
[Abstract/Free Full Text] - Kupersmith J, Hogan A, Guerrero P. Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J. 1995;130:507515[CrossRef][Web of Science][Medline]
- Wever EF, Hauer RN, Schrijvers G. Cost-effectiveness of implantable defibrillators as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation. 1996;93:489496
[Abstract/Free Full Text] - Valenti R, Schlapfer J, Fromer M, Fischer A, Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J. 1996;17:15651571
[Abstract/Free Full Text] - Mushlin AI, Zwanziger J, Gajary E, Andrews M, Marron R. Approach to cost-effectiveness assessment in the MADIT trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol. 1997;80:33F41F[CrossRef][Medline]
- Owens DK, Sanders GD, Harris RA. Cost-effectiveness of implantable cardioverter-defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:112
[Abstract/Free Full Text] - Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. PACE. 1989;12:366373
- Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J. 1994;127:11791184[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
A. M Tonkin GENERAL CARDIOLOGY: Evaluation of large scale clinical trials and their application to usual practice Heart, December 1, 2000; 84(6): 679 - 684. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
